This drug class, known as GLP-1 agonists, involves semaglutide—accepted as Ozempic for form two diabetes and Wegovy for being overweight—and tirzepatide—authorized as Mounjaro for diabetic issues and Zepbound https://neveqici200246.aboutyoublog.com/29333990/5-tips-about-weight-loss-pills-you-can-use-today